Koka, S., Das, A., Zhu, S., Durrant, D., Xi, L., & Kukreja, R. C. (2010). Long-Acting Phosphodiesterase-5 Inhibitor Tadalafil Attenuates Doxorubicin-Induced Cardiomyopathy without Interfering with Chemotherapeutic Effect. The American Society for Pharmacology and Experimental Therapeutics.

Koka, Saisudha, Anindita Das, Shu-Guang Zhu, David Durrant, Lei Xi, and Rakesh C. Kukreja. Long-Acting Phosphodiesterase-5 Inhibitor Tadalafil Attenuates Doxorubicin-Induced Cardiomyopathy Without Interfering With Chemotherapeutic Effect. The American Society for Pharmacology and Experimental Therapeutics, 2010.

Koka, Saisudha, et al. Long-Acting Phosphodiesterase-5 Inhibitor Tadalafil Attenuates Doxorubicin-Induced Cardiomyopathy Without Interfering With Chemotherapeutic Effect. The American Society for Pharmacology and Experimental Therapeutics, 2010.